Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 3, 2005 - Issue 2
Submit an article Journal homepage
573
Views
6
CrossRef citations to date
0
Altmetric
Editorial

Discovery of the antiviral activities of pharmacologic cyclin-dependent kinase inhibitors: from basic to applied science

Luis M Schang University of Alberta, Department of Biochemistry and Department of Medical Microbiology and Immunology, Signal Transduction Research Group, Molecular Mechanisms of Growth Control Research Group, 315C, HrtgMedRsch, Edmonton, Alberta, T6G 2S2, Canada. Tel.: +1 780 492 6265, Fax: +1 780 492 3383. [email protected]
Pages 145-149 | Published online: 10 Jan 2014

References

  • Rialet V, Meijer L. A new screening test for antimitotic compounds using the universal M phase-specific protein kinase, p34cdc2/cyclin Bcdc13, affinity-immobilized on p13suc1-coated microtitration plates. Anticancer Res. 11, 1581–1590 (1991).
  • Vesely J, Havlicek L, Strnad M et al. Inhibition of cyclin-dependent kinases by purine analogues. Euro. J. Biochem. 224, 771–786 (1994).
  • Parker CW, Entsch B, Letham DS. Inhibitors of two enzymes which metabolize cytokinins. Phytochem. Oxford 25, 303–310 (1986).
  • Meijer L, Borgne A, Mulner O et al. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Euro. J. Biochem. 243, 527–536 (1997).
  • Meijer L, Raymond E. Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials. Acc. Chem. Res. 36, 417–425 (2003).
  • Kaur G, Stetler-Stevenson M, Sebers S et al. Growth inhibition with reversible cell cycle arrest of carcinoma cells by flavone L86-8275. J. Natl Cancer Inst. 84, 1736–1740 (1992).
  • Losiewicz MD, Carlson BA, Kaur G, Sausville EA, Worland PJ. Potent inhibition of CDC2 kinase activity by the flavonoid L86-8275. Biochem. Biophys. Res. Commun. 201, 589–595 (1994).
  • Bresnahan WA, Boldogh I, Chi P, Thompson EA, Albrecht T. Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication. Virology 231, 239–247 (1997).
  • Schang LM, Phillips J, Schaffer PA. Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription. J. Virol. 72, 5626–5637 (1998).
  • Schang LM, Rosenberg A, Schaffer PA. Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases. J. Virol. 73, 2161–2172 (1999).
  • Jordan R, Schang L, Schaffer PA. Transactivation of herpes simplex virus Type 1 immediate-early gene expression by virion-associated factors is blocked by an inhibitor of cyclin-dependent protein kinases. J. Virol. 73, 8843–8847 (1999).
  • Schang LM, Rosenberg A, Schaffer PA. Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex-virus DNA synthesis in the presence of viral early proteins. J. Virol. 74, 2107–2120 (2000).
  • Diwan P, Lacasse JJ, Schang LM. Roscovitine inhibits activation of promoters in the HSV-1 genome independently of promoter-specific factors. J. Virol.78, 9352–9365 (2004).
  • Lacasse JJ, Provencher VMI, Urbanowski MD, Schang LM. Purine and nonpurine pharmacological cyclin-dependent kinase inhibitors target initiation of viral transcription. Therapy 2, 1–14 (2004).
  • Schang LM, Knockaert M, Shaheen F et al. Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of HSV and HIV-1 by targeting cellular, not viral proteins. J. Virol. 76, 7874–7882 (2002).
  • Chao SH, Fujinaga K, Marion JE et al. Flavopiridol inhibits P-TEFb and blocks HIV-1 replication. J. Biol. Chem. 275, 28345–28348 (2000).
  • Wang D, de la Fuente C, Deng L et al. Inhibition of human immunodeficiency virus Type 1 transcription by chemical cyclin-dependent kinase inhibitors. J. Virol. 75, 7266–7279 (2001).
  • Agbottah E, de la Fuente C, Nekhai S et al. Antiviral activity of CYC202 in HIV-1 infected cells. J. Biol. Chem. 280, 3029–3042 (2004).
  • van den Heuvel S, Harlow E. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262, 2050–2054 (1993).
  • Ortega S, Prieto I, Odajima J et al. Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nature Genet. 35, 25–31 (2003).
  • Tetsu O, McCormick F. Proliferation of cancer cells despite CDK2 inhibition. Cancer Cell 3, 233–245 (2003).
  • Berthet C, Aleem E, Coppola V, Tessarollo L, Kaldis P. Cdk2 knockout mice are viable. Curr. Biol. 13, 1775–1785 (2003).
  • Schang LM. Advances on cyclin-dependent kinases (CDKs) as novel targets for antiviral drugs. Curr. Drug Targets Infect. Disord. 5(1), 29–37 (2005).
  • Schang LM. Cellular proteins (cyclin dependent kinases) as potential targets for antiviral drugs. Antivir. Chem. Chemother. 12, 157–178 (2001).
  • Schang LM. Cyclin dependent kinases as cellular targets for antiviral drugs. J. Antimicrob. Chemother. 50, 779–792 (2002).
  • Nelson PJ, D’Agati VD, Gries J-M, Suarez J R, Gelman IH. Amelioration of nephropathy in mice expressing HIV-1 genes by the cyclin-dependent kinase inhibitor, flavopiridol. J. Antimicrob. Chemother. 51, 921–929 (2003).
  • Gherardi D, D’Agati V, Chu T-HT et al. Reversal of collapsing glomerulopathy in mice with the cyclin-dependent kinase inhibitor CYC202. J. Am. Soc. Nephrol. 15, 1212–1222 (2004).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.